Copyright Reports & Markets. All rights reserved.

Global Streptococcus Pneumoniae Vaccine Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Streptococcus Pneumoniae Vaccine Market Status and Forecast (2017-2028)
      • 1.3.2 Global Streptococcus Pneumoniae Vaccine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Streptococcus Pneumoniae Vaccine Supply by Company

    • 2.1 Global Streptococcus Pneumoniae Vaccine Sales Volume by Company
    • 2.2 Global Streptococcus Pneumoniae Vaccine Sales Value by Company
    • 2.3 Global Streptococcus Pneumoniae Vaccine Price by Company
    • 2.4 Streptococcus Pneumoniae Vaccine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Streptococcus Pneumoniae Vaccine Market Status by Type

    • 3.1 Streptococcus Pneumoniae Vaccine Type Introduction
      • 3.1.1 7 -Valent
      • 3.1.2 10 -Valent
      • 3.1.3 13 -Valent
      • 3.1.4 15 -Valent
      • 3.1.5 23 -Valent
      • 3.1.6 Other
    • 3.2 Global Streptococcus Pneumoniae Vaccine Market by Type
      • 3.2.1 Global Streptococcus Pneumoniae Vaccine Sales Volume by Type (2017-2022)
      • 3.2.2 Global Streptococcus Pneumoniae Vaccine Sales Value by Type (2017-2022)
      • 3.2.3 Global Streptococcus Pneumoniae Vaccine Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Streptococcus Pneumoniae Vaccine Market Status by Application

    • 4.1 Streptococcus Pneumoniae Vaccine Segment by Application
      • 4.1.1 Children under 2 Years of Age
      • 4.1.2 Adults over 65 Years of Age
      • 4.1.3 Addicted Smokers Between the Ages of 19 and 64
      • 4.1.4 Other
    • 4.2 Global Streptococcus Pneumoniae Vaccine Market by Application
      • 4.2.1 Global Streptococcus Pneumoniae Vaccine Sales Volume by Application (2017-2022)
      • 4.2.2 Global Streptococcus Pneumoniae Vaccine Sales Value by Application (2017-2022)
      • 4.2.3 Global Streptococcus Pneumoniae Vaccine Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Streptococcus Pneumoniae Vaccine Market Status by Region

    • 5.1 Global Streptococcus Pneumoniae Vaccine Market by Region
      • 5.1.1 Global Streptococcus Pneumoniae Vaccine Sales Volume by Region
      • 5.1.2 Global Streptococcus Pneumoniae Vaccine Sales Value by Region
    • 5.2 North America Streptococcus Pneumoniae Vaccine Market Status
    • 5.3 Europe Streptococcus Pneumoniae Vaccine Market Status
    • 5.4 Asia Pacific Streptococcus Pneumoniae Vaccine Market Status
    • 5.5 Central & South America Streptococcus Pneumoniae Vaccine Market Status
    • 5.6 Middle East & Africa Streptococcus Pneumoniae Vaccine Market Status

    6 North America Streptococcus Pneumoniae Vaccine Market Status

    • 6.1 North America Streptococcus Pneumoniae Vaccine Market by Country
      • 6.1.1 North America Streptococcus Pneumoniae Vaccine Sales Volume by Country (2017-2022)
      • 6.1.2 North America Streptococcus Pneumoniae Vaccine Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Streptococcus Pneumoniae Vaccine Market Status

    • 7.1 Europe Streptococcus Pneumoniae Vaccine Market by Country
      • 7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Streptococcus Pneumoniae Vaccine Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Streptococcus Pneumoniae Vaccine Market Status

    • 8.1 Asia Pacific Streptococcus Pneumoniae Vaccine Market by Country
      • 8.1.1 Asia Pacific Streptococcus Pneumoniae Vaccine Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Streptococcus Pneumoniae Vaccine Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Streptococcus Pneumoniae Vaccine Market Status

    • 9.1 Central & South America Streptococcus Pneumoniae Vaccine Market by Country
      • 9.1.1 Central & South America Streptococcus Pneumoniae Vaccine Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Streptococcus Pneumoniae Vaccine Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Streptococcus Pneumoniae Vaccine Market Status

    • 10.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Market by Country
      • 10.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Streptococcus Pneumoniae Vaccine Manufacturing Cost Analysis
    • 11.5 Streptococcus Pneumoniae Vaccine Sales Channel and Distributors Analysis
      • 11.5.1 Streptococcus Pneumoniae Vaccine Sales Channel
      • 11.5.2 Streptococcus Pneumoniae Vaccine Distributors
    • 11.6 Streptococcus Pneumoniae Vaccine Downstream Major Buyers

    12 Global Streptococcus Pneumoniae Vaccine Market Forecast by Type and by Application

    • 12.1 Global Streptococcus Pneumoniae Vaccine Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Streptococcus Pneumoniae Vaccine Forecast by Type
      • 12.2.1 Global Streptococcus Pneumoniae Vaccine Sales Volume Forecast by Type
      • 12.2.2 Global Streptococcus Pneumoniae Vaccine Sales Value Forecast by Type
      • 12.2.3 Global Streptococcus Pneumoniae Vaccine Price Forecast by Type
    • 12.3 Global Streptococcus Pneumoniae Vaccine Forecast by Application
      • 12.3.1 Global Streptococcus Pneumoniae Vaccine Sales Volume Forecast by Application
      • 12.3.2 Global Streptococcus Pneumoniae Vaccine Sales Value Forecast by Application
      • 12.3.3 Global Streptococcus Pneumoniae Vaccine Price Forecast by Application

    13 Global Streptococcus Pneumoniae Vaccine Market Forecast by Region/Country

    • 13.1 Global Streptococcus Pneumoniae Vaccine Market Forecast by Region (2023-2028)
      • 13.1.1 Global Streptococcus Pneumoniae Vaccine Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Streptococcus Pneumoniae Vaccine Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Valneva Austria
      • 14.1.1 Company Information
      • 14.1.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.1.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Sinovac
      • 14.2.1 Company Information
      • 14.2.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.2.3 Sinovac Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Serum Institute of India
      • 14.3.1 Company Information
      • 14.3.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.3.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Sanofi
      • 14.4.1 Company Information
      • 14.4.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.4.3 Sanofi Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 S K Chemicals
      • 14.5.1 Company Information
      • 14.5.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.5.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Pfizer
      • 14.6.1 Company Information
      • 14.6.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.6.3 Pfizer Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Panacea Biotec
      • 14.7.1 Company Information
      • 14.7.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.7.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Nuron Biotech
      • 14.8.1 Company Information
      • 14.8.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.8.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Merck
      • 14.9.1 Company Information
      • 14.9.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.9.3 Merck Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Lupin
      • 14.10.1 Company Information
      • 14.10.2 Streptococcus Pneumoniae Vaccine Product Introduction
      • 14.10.3 Lupin Streptococcus Pneumoniae Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 ImmunoBiology
    • 14.12 GSK
    • 14.13 Genocea Biosciences
    • 14.14 Genentech
    • 14.15 Eli Lilly
    • 14.16 Celgene Corporation
    • 14.17 Biogen
    • 14.18 Biken
    • 14.19 Beijing Minhai Biotechnology
    • 14.20 Baxter
    • 14.21 AstraZeneca
    • 14.22 Abera

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Streptococcus Pneumoniae Vaccine market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Streptococcus Pneumoniae Vaccine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Streptococcus Pneumoniae Vaccine market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Streptococcus Pneumoniae Vaccine Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Streptococcus Pneumoniae Vaccine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Streptococcus Pneumoniae Vaccine Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Streptococcus Pneumoniae Vaccine industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      7 -Valent
      10 -Valent
      Other

      Segmented by Application
      Children under 2 Years of Age
      Adults over 65 Years of Age
      Addicted Smokers Between the Ages of 19 and 64
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Serum Institute of India
      Sanofi
      S K Chemicals
      Pfizer
      Panacea Biotec
      Nuron Biotech
      Merck
      Lupin
      ImmunoBiology
      GSK
      Genocea Biosciences
      Genentech
      Eli Lilly
      Celgene Corporation
      Biogen
      Biken
      Beijing Minhai Biotechnology
      Baxter
      AstraZeneca
      Abera
      Buy now